Pamela L. Kunz, MD, on Pancreatic Neuroendocrine Tumors

Pamela L. Kunz, MD, on Pancreatic Neuroendocrine Tumors

ASCO News on CapTem chemotherapy trial Associate Professor Pamela L. Kunz*, MD, of the Yale University School of Medicine, discusses new findings from the ECOG-ACRIN E2211 trial (ClinicalTrials.gov Identifier: NCT01824875): Temozolomide With or Without Capecitabine in...

Unfortunately we are having to close our Helpline on Tuesday 6th October - however it will be open as usual on both Wednesday 7th and Thursday 8th.

X